Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-29
1996-10-22
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 17, 514 18, A61K 3807, A61K 3808
Patent
active
055676820
ABSTRACT:
The present invention relates to a method of treating the symptoms of Alzheimer's disease by the intranasal administration of a therapeutically effective amount of specific short chain peptides, in particular peptide T, to patients. Intranasal administration of the defined short chain peptides promotes neuronal survival for reducing or halting the progressive neuronal degeneration which occurs in Alzheimer's disease.
REFERENCES:
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4985242 (1991-01-01), Sekine et al.
patent: 5063206 (1991-11-01), Bridge et al.
Pert, C. B., et al., Psychopharmacology Bull., 24(3): 315-319, 1988.
Pert, C. B., et al. Ann. Neurol., 23 (Suppl.): S71-S73, 1988.
Pert, C. B., et al., Proc. Natl. Acad. Sci., USA, 83: 9254-9258, Dec. 1986.
Cecil Textbook of Medicine 19th ed. pp. 2076-2077 (1992).
Rosen et al, American Journal on Addictions vol. 1 p. 332 (1992).
Advanced Peptides and Biotechnology Sciences
Russel Jeffrey E.
LandOfFree
Method of treating Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358734